Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Aytu BioPharma Inc is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients. It has single operating segment. Its product portfolio includes EXXUA,...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Aytu BioPharma (NASDAQ:AYTU) through any online brokerage.
Other companies in Aytu BioPharma’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Aytu BioPharma has a consensus price target of $10.00.
The stock price for Aytu BioPharma (NASDAQ: AYTU) is $1.99 last updated .
There are no upcoming dividends for Aytu BioPharma.
Aytu BioPharma does not have any upcoming earnings scheduled.
There is no upcoming split for Aytu BioPharma.
Aytu BioPharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.